Euskara
|
Español
|
English
Sign in
Groups
Researchers
Results
JOSE ANTONIO
IRIBARREN LOYARTE
PROFESORADO ASOCIADO
Johns Hopkins University School of Medicine
Baltimore, Estados Unidos
You are in
Collaborations
Johns Hopkins University School of Medicine
Publications in collaboration with researchers from Johns Hopkins University School of Medicine (1)
2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
Accessibility
|
Legal information
|
Contact
|
Sitemap
|
Help
UPV/EHU